Literature DB >> 26192628

Permeapad™ for investigation of passive drug permeability: The effect of surfactants, co-solvents and simulated intestinal fluids (FaSSIF and FeSSIF).

Hanady Ajine Bibi1, Massimiliano di Cagno2, Rene Holm3, Annette Bauer-Brandl4.   

Abstract

The aim of the present work was to investigate the potential of the new and innovative artificial barrier, Permeapad™, when exposed to surfactants and co-solvents, often employed for poorly water soluble compounds. The barrier was in addition also exposed to fasted and fed state simulated intestinal fluids versions 1 and 2 (FaSSIF and FeSSIF), all of which the Permeapad™ barrier was compatible with based upon relative comparison of the permeability of the hydrophilic marker calcein in phosphate buffer. The new barrier therefore holds a huge potential due to its functional stability and robustness. It can be used as a standard tool to investigate permeability of drugs in the presence of different surfactants and co-solvents, from DMSO stock solutions at even high concentrations and for the evaluation of permeability in the presence of biomimetic media (BMM).
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apparent permeability; Caffeine (PubChem CID: 2519); Calcein (PubChem CID: 65079); Co-solvents; Dimethylsulphoxide (DMSO) (PubChem CID: 679); FaSSIF; FeSSIF; MacrogolG R (PubChem CID: 81307); Permeapad™; Polysorbate 80 (PubChem CID: 5284448); Sodiumdocecylsulphate (SDS) (PubChem CID: 8778); Surfactants; Triton-X (PubChem CID: 5590)

Mesh:

Substances:

Year:  2015        PMID: 26192628     DOI: 10.1016/j.ijpharm.2015.07.028

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Microfluidic system for immune cell activation and inflammatory cytokine profiling: Application to screening of dietary supplements for anti-inflammatory properties.

Authors:  Qasem Ramadan; Hawra Alawami; Mohammed Zourob
Journal:  Biomicrofluidics       Date:  2022-10-10       Impact factor: 3.258

2.  Human Lactobacillus Biosurfactants as Natural Excipients for Nasal Drug Delivery of Hydrocortisone.

Authors:  Elisa Corazza; Angela Abruzzo; Barbara Giordani; Teresa Cerchiara; Federica Bigucci; Beatrice Vitali; Massimiliano Pio di Cagno; Barbara Luppi
Journal:  Pharmaceutics       Date:  2022-02-26       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.